<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0003">
 <label>3</label>
 <mixed-citation publication-type="journal" id="CIT0003-gen-2">(a) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Yanovsky</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Finkin-Groner</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zaikin</surname>
    <given-names>A</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer’s disease</article-title>. 
  <source>J Med Chem</source>
  <year>2012</year>;
  <volume>55</volume>:
  <fpage>10700</fpage>–
  <lpage>15</lpage>.
  <pub-id pub-id-type="pmid">23151013</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0003-gen-3">(b) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhou</surname>
    <given-names>Q</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wu</surname>
    <given-names>XN</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease</article-title>. 
  <source>J Enzym Inhib Med Chem</source>
  <year>2019</year>;
  <volume>34</volume>:
  <fpage>260</fpage>–
  <lpage>70</lpage>.
 </mixed-citation>
</ref>
